Twist Bioscience Corp
TWST · XNASCIK 1581280fmd_03AFBG449YZKR0Q2JQ483PQA54Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Oct 01, 2016 to Jun 30, 2026, 36 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 11 | 25 | 54 | 90 | 132 | 204 | 245 | 313 | 377 |
| Cost of revenue | 24 | 32 | 47 | 61 | 81 | 119 | 155 | 180 | 186 |
| Gross profit | (13) | (7) | 7 | 29 | 52 | 84 | 90 | 133 | 191 |
| Realized investment gains (losses) | – | – | – | 0 | 0 | 0 | – | – | – |
| Research and development | 19 | 20 | 36 | 43 | 69 | 120 | 107 | 91 | 80 |
| Selling, general and administrative | 26 | 43 | 80 | 103 | 136 | 213 | 190 | 218 | 247 |
| Operating income | (58) | (71) | (109) | (140) | (153) | (235) | (217) | (221) | (136) |
| Interest expense | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | – |
| Interest and investment income | 0 | 1 | 3 | 1 | 0 | 3 | 14 | 15 | 11 |
| Other non-operating income (expense) | (0) | (0) | (0) | (0) | (1) | (1) | (1) | (3) | (1) |
| Income before taxes | (59) | (71) | (107) | (140) | (154) | (228) | (203) | (208) | (77) |
| Income tax expense | 0 | 0 | 0 | 0 | (2) | (10) | 1 | 1 | 1 |
| Net income from continuing operations | (59) | (71) | (108) | (140) | (152) | (218) | (205) | (209) | (78) |
| Net income | (59) | (71) | (108) | (140) | (152) | (218) | (205) | (209) | (78) |